Loading data for PLRX — first visit, this takes a few seconds.
Pliant Therapeutics Inc. (PLRX)
NasdaqGS: PLRX
· リアルタイム株価 · USD
1.12
-0.05 (-4.27%)
終値時点: Aug 21, 2026, 8:00 PM
1.16
+0.00%
時間外: 7:30 PM
株価、主要な数字、最新ニュースをひとまとめにしたページです。
Pliant Therapeutics Inc.(PLRX)の株価・分析・データ
-4.27% (1D)
データがありません
PLRXについて
Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integr...
企業情報の全文